155 related articles for article (PubMed ID: 36388028)
1. Prognostic impact of mitofusin 2 expression in colon cancer.
Cheng X; Li Y; Liu F
Transl Cancer Res; 2022 Oct; 11(10):3610-3619. PubMed ID: 36388028
[TBL] [Abstract][Full Text] [Related]
2. LncRNA PCAT6 is a predictor of poor prognosis of colorectal cancer.
Han L; Li Z; Zhang P; Sheng M; Wang W; Sun Y; Sun D
J Gastrointest Oncol; 2024 Feb; 15(1):190-202. PubMed ID: 38482211
[TBL] [Abstract][Full Text] [Related]
3. Correlation of autophagy-related genes for predicting clinical prognosis in colorectal cancer.
Liu L; Zhang J; Liu H; Shi M; Zhang J; Chen L; Huang L; Li B; Xu P
Biomark Med; 2021 Jun; 15(10):715-729. PubMed ID: 34169735
[No Abstract] [Full Text] [Related]
4. CCDC68 predicts poor prognosis in patients with colorectal cancer: a study based on TCGA data.
Zhang W; Xu TT; An ZT; Wei LF; Gu C; Li H; Tian YZ
J Gastrointest Oncol; 2022 Apr; 13(2):657-671. PubMed ID: 35557589
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive analysis of MFN2 as a prognostic biomarker associated with immune cell infiltration in renal clear cell carcinoma.
Cheng L; Wang Z; Nie L; Yang C; Huang H; Lin J; Zhuo D
Int Immunopharmacol; 2022 Oct; 111():109169. PubMed ID: 36007389
[TBL] [Abstract][Full Text] [Related]
6. Mitofusin-2 acts as biomarker for predicting poor prognosis in hepatitis B virus related hepatocellular carcinoma.
Wang X; Liu Y; Sun J; Gong W; Sun P; Kong X; Yang M; Zhang W
Infect Agent Cancer; 2018; 13():36. PubMed ID: 30498519
[TBL] [Abstract][Full Text] [Related]
7. Mitofusin 2 inhibits bladder cancer cell proliferation and invasion via the Wnt/β-catenin pathway.
Pang G; Xie Q; Yao J
Oncol Lett; 2019 Sep; 18(3):2434-2442. PubMed ID: 31402945
[TBL] [Abstract][Full Text] [Related]
8. High expression of PLAC1 in colon cancer as a predictor of poor prognosis: A study based on TCGA data.
Ren Y; Lv Y; Li T; Jiang Q
Gene; 2020 Dec; 763():145072. PubMed ID: 32827679
[TBL] [Abstract][Full Text] [Related]
9. The mitochondrial fusion-associated protein MFN2 can be used as a novel prognostic molecule for clear cell renal cell carcinoma.
Zhang B; Han D; Yang L; He Y; Yang S; Wang H; Zhang X; Du Y; Xiong W; Ha H; Shang P
BMC Cancer; 2023 Oct; 23(1):986. PubMed ID: 37845657
[TBL] [Abstract][Full Text] [Related]
10. TEAD4 functions as a prognostic biomarker and triggers EMT via PI3K/AKT pathway in bladder cancer.
Chi M; Liu J; Mei C; Shi Y; Liu N; Jiang X; Liu C; Xue N; Hong H; Xie J; Sun X; Yin B; Meng X; Wang B
J Exp Clin Cancer Res; 2022 May; 41(1):175. PubMed ID: 35581606
[TBL] [Abstract][Full Text] [Related]
11. Abnormal expression of ABCD3 is an independent prognostic factor for colorectal cancer.
Zhang Y; Zhang Y; Wang J; Yang J; Yang G
Oncol Lett; 2020 May; 19(5):3567-3577. PubMed ID: 32269631
[TBL] [Abstract][Full Text] [Related]
12. MiR-3614-5p Is a Potential Novel Biomarker for Colorectal Cancer.
Han L; Sun Y; Lu C; Ma C; Shi J; Sun D
Front Genet; 2021; 12():666833. PubMed ID: 34127929
[TBL] [Abstract][Full Text] [Related]
13. Upregulation of Stress-Induced Protein Kinase CK1 Delta is associated with a Poor Prognosis for patients with Hepatocellular Carcinoma.
Zhang H; Qiu C; Zeng H; Zhu W; Lyu W; Lao X
Genet Test Mol Biomarkers; 2021 Jul; 25(7):504-514. PubMed ID: 34280005
[No Abstract] [Full Text] [Related]
14. Identification of a glycolysis- and lactate-related gene signature for predicting prognosis, immune microenvironment, and drug candidates in colon adenocarcinoma.
Liu C; Liu D; Wang F; Xie J; Liu Y; Wang H; Rong J; Xie J; Wang J; Zeng R; Zhou F; Peng J; Xie Y
Front Cell Dev Biol; 2022; 10():971992. PubMed ID: 36081904
[No Abstract] [Full Text] [Related]
15. TPMT mRNA Expression: A Novel Prognostic Biomarker for Patients with Colon Cancer by Bioinformatics Analysis.
Jia W; He YF; Qian XJ; Chen J
Int J Gen Med; 2022; 15():151-160. PubMed ID: 35023953
[TBL] [Abstract][Full Text] [Related]
16. CDCA8 as an independent predictor for a poor prognosis in liver cancer.
Shuai Y; Fan E; Zhong Q; Chen Q; Feng G; Gou X; Zhang G
Cancer Cell Int; 2021 Mar; 21(1):159. PubMed ID: 33685433
[TBL] [Abstract][Full Text] [Related]
17. Construction of mRNA prognosis signature associated with differentially expressed genes in early stage of stomach adenocarcinomas based on TCGA and GEO datasets.
Jiang F; Lin H; Yan H; Sun X; Yang J; Dong M
Eur J Med Res; 2022 Oct; 27(1):205. PubMed ID: 36253873
[TBL] [Abstract][Full Text] [Related]
18. INSC Is Down-Regulated in Colon Cancer and Correlated to Immune Infiltration.
Yu T; Li D; Zeng Z; Xu X; Zhang H; Wu J; Song W; Zhu H
Front Genet; 2022; 13():821826. PubMed ID: 35664320
[No Abstract] [Full Text] [Related]
19. Expression of ubiquitin-conjugating enzyme E2T in colorectal cancers and clinical implications.
Wu X; Liu G; Liu R; He J; Wang G; Zhang H; Liu T; Bai J; Cheng N; Qiu J
Oncol Lett; 2020 Nov; 20(5):275. PubMed ID: 33014154
[TBL] [Abstract][Full Text] [Related]
20. A Novel Hypoxia-Related Gene Signature with Strong Predicting Ability in Non-Small-Cell Lung Cancer Identified by Comprehensive Profiling.
Yang H; Wang Z; Gong L; Huang G; Chen D; Li X; Du F; Lin J; Yang X
Int J Genomics; 2022; 2022():8594658. PubMed ID: 35634481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
